Indrayani Biotech Limited (BOM:526445)
14.97
+0.28 (1.91%)
At close: Oct 24, 2025
Indrayani Biotech Revenue
Indrayani Biotech had revenue of 295.54M INR in the quarter ending June 30, 2025, a decrease of -33.41%. This brings the company's revenue in the last twelve months to 1.28B, down -22.84% year-over-year. In the fiscal year ending March 31, 2025, Indrayani Biotech had annual revenue of 1.30B, down -21.66%.
Revenue (ttm)
1.28B
Revenue Growth
-22.84%
P/S Ratio
0.53
Revenue / Employee
1.37M
Employees
936
Market Cap
681.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.30B | -359.97M | -21.66% |
| Mar 31, 2024 | 1.66B | 32.96M | 2.02% |
| Mar 31, 2023 | 1.63B | 1.01B | 164.57% |
| Mar 31, 2022 | 615.82M | 403.91M | 190.60% |
| Mar 31, 2021 | 211.91M | -287.06M | -57.53% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.04T |
| State Bank of India | 3.50T |
| Larsen & Toubro | 2.69T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| ICICI Bank | 1.91T |
| Bharti Airtel | 1.84T |